Dr. Jamie Cesaretti MD

Dr. Cesaretti joined Florida Radiation Oncology Group, in 2008, where he and his group do approximate 500 implant procedures a year, after having been an assistant Professor of Radiation Oncology Mount Sinai School of Medicine from 2004-2008.

He has a particular interest in helping patients make the right personal decision regarding their cancer care among an often-overwhelming array of potential treatment choices. He has published many papers on the outcomes of men treated with LDR brachytherapy. The topics include the outcomes of younger men, the efficacy of tri-modality treatment for higher risk prostate cancer and the correlations of late side effects with genetics and dose-volume constraints. 

In addition, he continues to contribute to studies currently funded by the American Cancer Society, the NIH and the Department of Defense that focus on the radiogenomics of men treated for prostate cancer.

Bengt Johansson

Bengt Johansson is a Senior Consultant in Surgical Oncology and Radiotherapy at the Department of Oncology at Örebro University Hospital, Sweden, where he started in 1984.

He has been focused on clinical development and research of many types brachytherapy since the early 1990’s including HDR monotherapy for prostate cancer.

Dr. Stefan Machtens, Germany

Having introduced prostate brachytherapy in Hanover, Stefan moved to Marien-Krankenhaus Bergisch Gladbach to become Head of the Department of Urology in 2006.

Dr Machtens has introduced a web based brachytherapy database for European Centres using the real time technique. Dr Machtens has been a member of the German Society of Urology since 1995 and was awarded "Young Innovator in Urology" in 2000.

Between 2003 - 2005 he was elected to the academic staff of Hannover Medical School In 2005, he was appointed to the Scientific Advisory Board of the Federal Association of prostate cancer Support. In 2007 he assisted the German Society of Urology in writing the prostate cancer guidelines.

Dr. Jim Morris, Canada

Dr. Jim Morris, Canada Dr. Morris studied medicine at the University of British Columbia in Canada, graduated in 1985, and did his residency in Radiation Oncology at the BCCA. He started on staff in 1991 after completing a clinical research fellowship in the UK.

Dr. Morris is one of the founders and the former head (1997-2008) of the British Columbia Provincial Prostate Brachytherapy Program which is the largest prostate brachytherapy program in Canada having done more than 3000 implants to date. Dr. Morris and his colleagues have published > 25 refereed publications and have presented dozens of abstracts at national and international meeting detailing various aspects of brachytherapy for prostate cancer. In addition to a full time clinical practise in radiation oncology,

Dr. Morris holds a number of peer-reviewed and industry-sponsored research grants, participates in the supervision of clinical/research fellows, graduate students, radiation oncology residents and medical undergraduates. Dr. Morris is currently the chair of the Brachytherapy Quality Assurance Committee and is the principle investigator for developmental brachytherapy at the Vancouver Cancer Centre.